Sam is a member of Oxera’s Competition and Pharmaceuticals & Life Sciences teams. He has worked on a wide range of competition issues in a variety of sectors, including merger investigations by both the European Commission and the UK Competition and Markets Authority (CMA), follow-on antitrust damages, abuse of dominance cases, and market investigations. He also has experience of damages quantification in the pharmaceutical sector.
In 2021, Sam completed a six-month secondment as an economist at the CMA. During this time, he worked on merger investigations, including a large phase 2 merger in the transportation and storage industry.
Prior to joining Oxera, Sam completed a BSc and an MSc in Economics at the University of Warwick, focusing on econometrics and competition economics. Since joining, he has also completed an MSc in Economics at the University of Warwick.
Sam speaks English.
Tel: +44 (0) 1865 253065